CSO statistical release, 22 March 2018, 11am
HSE Funded Optical Treatments
Number of optical treatments falls by 1,400 between 2013 and 2015.
go to full release
The number of Health Service Executive (HSE) funded treatments under the Community Ophthalmic Services Scheme (COSS) fell from 770.8 thousand in 2013 to 769.4 thousand in 2015. This is less than 1% of a reduction.
These payments were paid for by the Primary Care Reimbursement Service (PCRS). Please see background notes for a further description of the PCSR and COSS.
- The supply of appliances is the most commonly carried out optical procedure, accounting for over 50% of all publicly-funded treatments each year. The second most commonly performed treatment is eye examinations, which makes up approximately 38% of the total number of treatments each year. Home visits by opticians or ophthalmologists are the least carried out form of treatment, making up approximately 1.3% of the total number of treatments. See Table 1 and Figure 1.
- In 2015, 453.9 thousand publicly funded dental treatments were carried out on females compared with 315.5 thousand on males. The corresponding figures for 2013 are 451.6 thousand and 319.2 thousand respectively. See Table 2.
- The South region had the highest number of publicly funded optical treatments in 2015, with 223.3 thousand. The lowest number of treatments was carried out in the Dublin North-East region, where 142.5 thousand were carried out.
- The age group with the highest number of treatments each year if the 75 years and older age group. This was 214.7 thousand in 2015 and 216.3 thousand in 2013. The age group with the lowest number of treatments is the 25-34 years old age group, with 35.5 thousand in 2015 and 37.8 thousand in 2013. See Table 2.
- The average number of claims per person was 2.1 in 2013. This rose to 2.2 in 2014 and 2015. See Table 3.
- The number of cataract treatments each year is approximately 3.8 thousand. The number of treatments carried out for glaucoma is approximately 4.5 thousand. See Table 4 and Figure 2.